Exploring Buccal Prochlorperazine: A Targeted Review of Its Pharmacological Profile
The Clinical Value of Buccal Prochlorperazine Prochlorperazine remains a clinically valuable agent for managing nausea, dizziness, vertigo, and vestibular migraine. (1) However, oral administration is often limited by variable absorption, significant first-pass metabolism, and poor tolerability in symptomatic patients. With such clinical needs, buccal delivery serves as a relevant treatment option with potential advantages in […]